Fight your fear of hospitals: it could save your life
When you see hospitals through the prism of the media, it’s no wonder you view them as little more than germ-infested harbourers of superbugs. Every day, a new headline states, “MRSA SCARE IN HOSPITALS!” or More...
New study highlights Illinois abortion clinics ‘dangerous’ conditions
A new study says Illinois is facing a serious women’s health crisis and the Illinois Department of Public Health is receiving the heat for the crisis. A new report, released by Illinois Right to Life, documents More...
Johns Hopkins study: New UV Light Decontamination System effective against MRSA, HIV, C Diff, others
Spectra254, a developer of high-power, easy-to-use, affordable UVC light decontamination systems, has released a recent study by Johns Hopkins Medicine that reports that Spectra254’s Spectra 1000 Series of UV More...
Phase I study for MRSA, VISA drug, Debio 1450 launched
Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase More...
Dalvance receives FDA approval for the treatment of Staph and Strep skin infections
PRESS RELEASE The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. MRSAImage/CDC Dalvance is intended to treat acute bacterial More...
WHO releases report on antibiotic resistance
NEWS RELEASE 30 APRIL 2014 | GENEVA – A new report by WHO–its first to look at antimicrobial resistance, including antibiotic resistance, globally–reveals that this serious threat is no longer a prediction More...
Vancomycin-resistant MRSA superbug found in Brazil
PRESS RELEASE An international research team led by Cesar A. Arias, M.D., Ph.D., at The University of Texas Health Science Center at Houston (UTHealth) has identified a new superbug that caused a bloodstream infection More...
Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee
PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...
Healthcare-associated infections: 722,000 infections in 2011 in the US according to CDC data
On any given day, approximately one in 25 U.S. patients has at least one infection contracted during the course of their hospital care, adding up to about 722,000 infections in 2011, according to new data from the More...
UCLA researchers issue guidelines on the treatment and management of MRSA skin abscesses
It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent More...
Notre Dame researchers discover ‘oxadiazoles’, a new class of antibiotics for MRSA treatment
A new class of antibiotics have been discovered that show promise in treating difficult to treat infections caused by Methicillin Resistant Staphylococcus aureus (MRSA) and other threats to public health. MRSAImage/CDC Researchers More...
New Use For Antipsychotic Drug Holds Promise for Tuberculosis Cure
The increase in antibiotic resistance is coming at a bad time, as more and more pharmaceutical companies begin downsizing or eliminating their antimicrobial research branches due to lack of profits. Fearing a More...
FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections
PRESS RELEASE Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...
Becton Dickinson receives FDA clearance to market the BD MAX™ StaphSR Assay
Press Release BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced yesterday it has received FDA clearance to market the BD MAX™ StaphSR More...
Narrow-spectrum ultraviolet light could dramatically reduce surgical infections from organisms like MRSA: Study
New research suggests that narrow-spectrum ultraviolet (UV) light could dramatically reduce surgical wound infections such as those caused by MRSA, according to a study by Columbia University Medical Center More...
Buccaneers report third player with MRSA, call on DICON to help
In a follow up to a report of two Tampa Bay Buccaneers being infected with Methicillin-resistant Staphylococcus aureus, or more commonly known as MRSA, ESPN is reporting a third Buc contracting the antibiotic-resistant More...
Duke advises NFL on use of chlorhexidine gluconate to prevent MRSA
With reports of the antibiotic resistant bacterial strain, Methicillin-resistant Staphylococcus aureus, or more commonly known as MRSA, in high contact sports like football and wrestling, researchers are looking More...
MRSA infections down in all categories, hospital acquired down more than 50% according to study
Infections caused by Methicillin-resistant Staphylococcus aureus, or MRSA, has decreased in all settings, according to new data published in The Journal of the American Medical Association (JAMA), Internal Medicine More...
Buccaneers, Carl Nicks and Lawrence Tynes sidelined with MRSA infections, One Buc Place sanitized
Two Tampa Bay Buccaneers have been diagnosed with Methicillin-resistant Staphylococcus aureus, better known as MRSA infections prompting the signing of a new kicker and a thorough sanitizing of One Buc Place. Credits: More...
UC San Diego scientists discover ‘anthracimycin’, compound that kills anthrax, MRSA
Researchers from Scripps Institution of Oceanography at UC San Diego have discovered a compound from a microbe from the ocean that shows lethality against such bacterial pathogens as anthrax and MRSA and may set More...
